Subtype
Hepatopancreatobiliary Carcinoma
CI-CAN-00002859Explore in graph →
1,361 active trials21 approved drugs69 evidence items
- NCIt
- C214986
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00002859Explore in graph →
Clinical trials
5,154 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (646)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00769106 | Study of Cytokine-induced Killer Cell (CIK) Treatment in Patients After Resection of Liver Cancer(HCC-CIK) | completed | Phase 3 | 200 | Sun Yat-sen UniversityOTHER | 1 | Apr 14, 2016 | clinicaltrials |
| NCT01749865 | CIK Treatment for HCC Patient Underwent Radical Resection | completed | Phase 3 | 200 | Sun Yat-sen UniversityOTHER | 1 | Apr 14, 2016 | clinicaltrials |
| NCT01814631 | Endoscopic Ultrasound (EUS) Processor Comparison | withdrawn | — | 0 | AdventHealthOTHER | 1 | Apr 14, 2016 | clinicaltrials |
| NCT02301091 | Combine TACE and RFA Versus TACE Alone for HCC With PVTT(CORTT) | unknown | Phase 3 | 240 | Ming ZhaoOTHER | 1 | Apr 14, 2016 | clinicaltrials |
| NCT02479178 | A Study of BIND-014 in Patients With Urothelial Carcinoma, Cholangiocarcinoma, Cervical Cancer and Squamous Cell Carcinoma of the Head and Neck(iNSITE2) | terminated | Phase 2 | 73 | BIND TherapeuticsINDUSTRY | 2 | Apr 14, 2016 | clinicaltrials |
| NCT00241020 | Evaluation of the Efficacy of Long-acting Release Octreotide in Patients With Advanced Hepatocellular Carcinoma | completed | Phase 3 | 270 | Novartis PharmaceuticalsINDUSTRY | 0 | Apr 12, 2016 | clinicaltrials |
| NCT01488487 | Everolimus and Pasireotide (SOM230) in Patients With Advanced or Metastatic Hepatocellular Carcinoma | completed | Phase 2 | 24 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Apr 7, 2016 | clinicaltrials |
| NCT02423239 | A Study of Dexanabinol in Combination With Chemotherapy in Patients With Advanced Tumours | unknown | Phase 1 | 112 | e-Therapeutics PLCINDUSTRY | 4 | Apr 6, 2016 | clinicaltrials |
| NCT02729506 | Transarterial Radioembolization Versus Chemoembolization for the Treatment of Hepatocellular Carcinoma | unknown | Phase 4 | 150 | King Faisal Specialist Hospital & Research CenterOTHER | 1 | Apr 6, 2016 | clinicaltrials |
| NCT02683538 | Radiofrequency Ablation Using Octopus Electrodes for Treatment of Focal Liver Malignancies | completed | Phase 2 | 196 | Seoul National University HospitalOTHER | 1 | Apr 5, 2016 | clinicaltrials |
| NCT02728193 | Standard Treatments of Very-early Stage Hepatocellular Carcinoma | completed | N/A | 300 | Eastern Hepatobiliary Surgery HospitalOTHER | 1 | Apr 5, 2016 | clinicaltrials |
| NCT02728219 | Comparison of Treatment of Recurrent HCC With Repeat Hepatectomy,and TACE With AFP Conversion(HCCTACEAFP) | completed | N/A | 150 | Eastern Hepatobiliary Surgery HospitalOTHER | 1 | Apr 5, 2016 | clinicaltrials |
| NCT00872014 | A Study of the Effectiveness and Safety of AMG 386 and Sorafenib to Treat Advanced or Inoperable Hepatocellular Cancer | completed | Phase 2 | 60 | AmgenINDUSTRY | 0 | Apr 4, 2016 | clinicaltrials |
| NCT00926536 | Impact of C-arm CT in Patients With HCC Undergoing TACE: Optimal Imaging Guidance | completed | N/A | 84 | Stanford UniversityOTHER | 1 | Apr 4, 2016 | clinicaltrials |
| NCT02727309 | A Study of Second-line Treatment With Apatinib After TACE in Advanced Hepatocellular Carcinoma Patients | unknown | Phase 1 / Phase 2 | 30 | Peking University Cancer Hospital & InstituteOTHER | 1 | Apr 4, 2016 | clinicaltrials |
| NCT02727673 | Relationship Between Circulating Tumor Stem Cells and the Clinical Pathology | completed | — | 1,000 | Eastern Hepatobiliary Surgery HospitalOTHER | 1 | Apr 4, 2016 | clinicaltrials |
| NCT00814242 | Hepatectomy Versus Radiofrequency Ablation for Hepatocellular Carcinoma Adjacent to Major Blood Vessels | completed | Phase 2 / Phase 3 | 120 | Eastern Hepatobiliary Surgery HospitalOTHER | 1 | Apr 1, 2016 | clinicaltrials |
| NCT00819650 | A Trial of Licartin for Preventing Tumor Recurrence After Liver Resection | completed | Phase 2 | 200 | Eastern Hepatobiliary Surgery HospitalOTHER | 1 | Apr 1, 2016 | clinicaltrials |
| NCT00820053 | A Trial of Adjuvant Transarterial Chemoembolization (TACE) for Preventing Tumor Recurrence After Liver Resection | completed | Phase 2 | 450 | Eastern Hepatobiliary Surgery HospitalOTHER | 1 | Apr 1, 2016 | clinicaltrials |
| NCT00820339 | Pringle's Maneuver Versus Selective Hepatic Vascular Exclusion in Hepatectomy(SHVE) | completed | Phase 2 / Phase 3 | 132 | Eastern Hepatobiliary Surgery HospitalOTHER | 1 | Apr 1, 2016 | clinicaltrials |
| NCT00822562 | Research on Surgery and Micro-Invasive Treatment in Recurrent Primary Liver Cancer | completed | N/A | 100 | Eastern Hepatobiliary Surgery HospitalOTHER | 1 | Apr 1, 2016 | clinicaltrials |
| NCT00825474 | A Prospective Randomized Trial Comparing Partial Hepatectomy and TACE Plus PEI for Small Hepatocellular Carcinoma | completed | N/A | 160 | Eastern Hepatobiliary Surgery HospitalOTHER | 1 | Apr 1, 2016 | clinicaltrials |
| NCT00825669 | Treatment of Portal Vein Tumor Thrombus After Hepatocellular Carcinoma Resection | completed | N/A | 100 | Eastern Hepatobiliary Surgery HospitalOTHER | 1 | Apr 1, 2016 | clinicaltrials |
| NCT00826384 | Transarterial Chemoembolization (TACE) Therapy of Hepatocellular Carcinoma (HCC) With Blocking Tumor Blood Temporarily and Enhancing Perfusion | completed | Phase 1 / Phase 2 | 352 | Eastern Hepatobiliary Surgery HospitalOTHER | 1 | Apr 1, 2016 | clinicaltrials |
| NCT00827047 | Total Hemihepatic Vascular Exclusion in Hepatectomy in Hepatocellular Carcinoma Treatment | completed | N/A | 150 | Eastern Hepatobiliary Surgery HospitalOTHER | 1 | Apr 1, 2016 | clinicaltrials |
| NCT00827554 | The Role of Low Molecular Weight Heparins in Hepatocellular Carcinoma | completed | Phase 2 / Phase 3 | 100 | Eastern Hepatobiliary Surgery HospitalOTHER | 1 | Apr 1, 2016 | clinicaltrials |
| NCT00829465 | Clinical Research of Licartin Combined With TACE in the Treatment of Unresectable Hepatocellular Carcinoma | completed | Phase 4 | 400 | Eastern Hepatobiliary Surgery HospitalOTHER | 0 | Apr 1, 2016 | clinicaltrials |
| NCT00834158 | Efficacy of Sequential TACE and PVE on the Resectability of Hepatitis B Related HCC(TACEPVE) | completed | N/A | 20 | Eastern Hepatobiliary Surgery HospitalOTHER | 1 | Apr 1, 2016 | clinicaltrials |
| NCT00849264 | Comprehensive Treatment for Different Types of Tumor Thrombi in the Portal Vein for Hepatocellular Carcinoma Patients | completed | Phase 2 | 120 | Eastern Hepatobiliary Surgery HospitalOTHER | 1 | Apr 1, 2016 | clinicaltrials |
| NCT00851968 | A Trial of Complete Versus Selective HepaticVascular Clamping in Hepatectomy | completed | N/A | 320 | Eastern Hepatobiliary Surgery HospitalOTHER | 1 | Apr 1, 2016 | clinicaltrials |
| NCT01786980 | The Methylation Phenotype Screening and Determination Mode Study of Liver Cancer Prognosis Related Gene | completed | — | 300 | Eastern Hepatobiliary Surgery HospitalOTHER | 1 | Apr 1, 2016 | clinicaltrials |
| NCT02338297 | Therapeutic Effect of Ethanol-gelfoam Mixture for the Treatment of Arterioportal Shunts (APS) in Patients With HCC | unknown | Phase 3 | 236 | Nanjing Medical UniversityOTHER | 1 | Apr 1, 2016 | clinicaltrials |
| NCT02526771 | Conventional or Unconventional Lymph Node Dissection During Resection of Intrahepatic Cholangiocarcinoma | unknown | N/A | 100 | Eastern Hepatobiliary Surgery HospitalOTHER | 1 | Apr 1, 2016 | clinicaltrials |
| NCT02586285 | Effect of S-Adenosyl Methionine Treatment on Recurrence After Curative Resection of Hepatocellular Carcinoma | unknown | Phase 1 | 300 | Eastern Hepatobiliary Surgery HospitalOTHER | 1 | Apr 1, 2016 | clinicaltrials |
| NCT00817895 | Intraoperative Chemotherapy Against Hepatocellular Carcinoma Recurrence | completed | N/A | 150 | Eastern Hepatobiliary Surgery HospitalOTHER | 1 | Mar 31, 2016 | clinicaltrials |
| NCT01643447 | Ulinastatin Preventing Postoperative Hepatic Failure in Hepatocellular Carcinoma (HCC) | completed | N/A | 200 | Eastern Hepatobiliary Surgery HospitalOTHER | 1 | Mar 31, 2016 | clinicaltrials |
| NCT01717066 | the Efficacy and Safety of Ginsenoside Rg3 Capsule in Prevention of Postoperative Recurrence of Hepatocellular Carcinoma(Rg3) | completed | N/A | 480 | ShenFengOTHER | 1 | Mar 31, 2016 | clinicaltrials |
| NCT01860222 | Surgical Resection Versus Percutaneous Local Ablative Therapy for Hepatocellular Carcinoma | unknown | N/A | 160 | Eastern Hepatobiliary Surgery HospitalOTHER | 1 | Mar 31, 2016 | clinicaltrials |
| NCT01914289 | Prognosis of Resection and Radiotherapy in the Treatment of Intrahepatic Cholangiocarcinoma Patients | unknown | N/A | 200 | Eastern Hepatobiliary Surgery HospitalOTHER | 1 | Mar 31, 2016 | clinicaltrials |
| NCT01923948 | Preoperative Pain Control in Liver Surgery Patients | completed | N/A | 40 | Eastern Hepatobiliary Surgery HospitalOTHER | 1 | Mar 31, 2016 | clinicaltrials |
| NCT02525952 | Treatment for Patients With Multiple Hepatocellular Carcinomas Based on the NDR Scoring System | unknown | N/A | 320 | Eastern Hepatobiliary Surgery HospitalOTHER | 1 | Mar 31, 2016 | clinicaltrials |
| NCT02525965 | The Influence of Resection Margin on the Recurrence of Early-stage Hepatocellular Carcinoma | unknown | N/A | 194 | Eastern Hepatobiliary Surgery HospitalOTHER | 1 | Mar 31, 2016 | clinicaltrials |
| NCT02587884 | Anti-recurrence Treatment of Postresection on HCC Patients With MVI Presence and Over-expression of ASPH | unknown | Phase 1 | 180 | Eastern Hepatobiliary Surgery HospitalOTHER | 1 | Mar 31, 2016 | clinicaltrials |
| NCT02588755 | TACE Plus Tegafur Versus TACE for Intrahepatic Cholangiocarcinoma After Curative Resection | unknown | N/A | 180 | Eastern Hepatobiliary Surgery HospitalOTHER | 1 | Mar 31, 2016 | clinicaltrials |
| NCT02724267 | Targeted Internal Radiation Therapy in Advanced HCC Patients. | completed | N/A | 200 | Eastern Hepatobiliary Surgery HospitalOTHER | 1 | Mar 31, 2016 | clinicaltrials |
| NCT02724332 | Adjuvant Anti-Recurrence Treatment With Rapamycin on Early-stage HCC | completed | Phase 1 | 300 | Eastern Hepatobiliary Surgery HospitalOTHER | 1 | Mar 31, 2016 | clinicaltrials |
| NCT02724345 | Postoperative Adjuvant TACE Treatment in CK18 Positive Patients | completed | — | 320 | Eastern Hepatobiliary Surgery HospitalOTHER | 1 | Mar 31, 2016 | clinicaltrials |
| NCT02724358 | Rg3 in Combination With TACE in Hepatocellular Carcinoma Patients With High Expression of Notch1 | completed | N/A | 320 | Eastern Hepatobiliary Surgery HospitalOTHER | 1 | Mar 31, 2016 | clinicaltrials |
| NCT02724436 | Radioembolization With Yittrium-90 for Intermediate and Advanced Hepatocellular Carcinoma | completed | N/A | 200 | Eastern Hepatobiliary Surgery HospitalOTHER | 1 | Mar 31, 2016 | clinicaltrials |
| NCT02724475 | Laser Ablation for Intermediate and Advanced Hepatocellular Carcinoma With Portal Vein Tumor Thrombus | completed | N/A | 180 | Eastern Hepatobiliary Surgery HospitalOTHER | 1 | Mar 31, 2016 | clinicaltrials |
Data updated 23 days agoSource updated Apr 14, 2016source: clinicaltrials